Compared to autoDCs, alloDCs are more capable of inducing specific immune responses because they can more broadly activate CD8+ T cell immunity, including tumor-responsive T cells and broad inflammatory responses by polyclonal stimulation of allogeneic T cells [5,6]. Here, CD8A is linked to neoplasm.